Leah Rush

Stock Analyst at Brookline Capital

(2.10)

# 2,841

Out of 4,761 analysts

2

Total ratings

100%

Success rate

3.42%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Leah Rush

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	EXEL Exelixis	Initiates: Buy	n/a	$36.85	-	1	Dec 23, 2024
	SYRS Syros Pharmaceuticals	Downgrades: Hold	n/a	$0.17	-	1	Nov 13, 2024

Exelixis

Dec 23, 2024

Initiates: Buy

Price Target: n/a

Current: $36.85

Upside: -

Syros Pharmaceuticals

Nov 13, 2024

Downgrades: Hold

Price Target: n/a

Current: $0.17

Upside: -